Follow us on Twitter
This page is updated frequently with new Gly-related patent applications. Subscribe to the Gly RSS feed to automatically get the update: related Gly RSS feeds. RSS updates for this page: Gly RSS
|| List of recent Gly-related patents
| Soybean transgenic event mon87751 and methods for detection and use thereof|
The invention provides a transgenic glycine max event mon87751, plants, plant cells, seeds, plant parts, progeny plants, and commodity products comprising event mon87751. The invention also provides polynucleotides specific for event mon87751, plants, plant cells, seeds, plant parts, and commodity products comprising polynucleotides for event mon87751.
| Transgenic brassica event mon 88302 and methods of use thereof|
The invention provides plants comprising transgenic event mon 88302 that exhibit tolerance to glyphosate herbicide. The invention also provides seeds, plant parts, cells, commodity products, and methods related to the event.
| Methods of converting polyols|
Methods for converting polyols are provided. The methods provided can include using a metal pincer catalyst (e.g., an iridium pincer catalyst) to remove at least one alcohol group from a polyol.
| Synthetic acid and associated methods|
Glycine is an organic compound that can be used in the making of a synthetic acid that obviates all the drawbacks of strong acids such as hydrochloric acid. The new compound is made by dissolving glycine in water, in a weight ratio of approximately 1:1 to 1:1.5.
| Pamam, spacer molecule and cafestol polymers|
The present invention is directed to a polymeric compound with a size in a nanometric scale, useful as a biocompatible carrier for the transport and delivery of active agents into a fish, insect, animal, reptile, bird, human, or plant, wherein said polymeric compound comprises pamam (polyamidoamine) dendrimers, a spacer molecule, and cafestol, wherein the polymeric compound of the invention comprises a structure of the kind (cafestol-pamam derivative)2-spacer molecule. Use of the compound as a biocompatible carrier for transport and delivery of antithrombotic active agents is disclosed.
| Surfactant composition|
The present invention provides a surfactant composition containing a polyglycerol alkyl ether which is capable of exhibiting a high emulsification performance for silicone oils compounded in cosmetics, detergents, etc., by using a natural alcohol derived from oils and fats as a raw material thereof, a process for producing the surfactant composition in an effective manner, and a use of the surfactant composition. The present invention relates to  a surfactant composition including a specific polyglycerol monoalkyl ether (1) and a specific polyglycerol dialkyl ether (2), a mass ratio of [(1)/(2)] being from 65/35 to 75/25;  a process for producing the surfactant composition;  an emulsifier composition including the surfactant composition; and  a detergent composition including the surfactant composition..
| Orally-disintegrating formulations of flurbiprofen|
The present invention relates to an orally-disintegrating pharmaceutical formulation, which is characterized by comprising flurbiprofen and polyvinylcaprolactam-polyvinyl acetate-polyethylene glycol graft copolymer.. .
| Glycopyrrolate salts|
Salts of glycopyrrolate, including solid forms and formulations such as topicals thereof, are disclosed. Methods of making glycopyrrolate salts, including formulations such as topicals thereof, and methods of treating hyperhidrosis with salts of glycopyrrolate, and formulations such as topicals thereof, are disclosed..
| Composition for elimination of troublesome varmints|
Composition for elimination of troublesome varmints comprises all the non-essential amino acids alanine, glycine, proline, serine, tyrosine, aspartic acid, asparagine, glutamic acid.. .
| Novel piperine derivatives and uses thereof|
The present invention provides novel piperine derivatives. The present pharmaceutical or food composition containing a piperine derivative as an active ingredient is very effective in preventing or treating metabolic diseases including obesity, diabetes, dyslipidemia, fatty liver and insulin resistance syndrome.
| Phenyl methanesulfonamide derivatives useful as mgat-2 inhibitors|
The present invention provides compounds of formula i or a pharmaceutical salt thereof, where the variables for r1, r2, and r3 are as described herein; methods of treating a condition such as hypertriglyceridemia; and processes for preparing the compounds.. .
| 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators|
R4 is hydrogen or a c1-4 hydrocarbyl group optionally substituted by halogen (e.g. Fluorine), hydroxyl or c1-4 alkoxy (e.g.
| Glycoprotein hormone long-acting superagonists|
This invention provides long-acting, superactive analogs of glycoprotein hormones demonstrating enhanced bioactivity both in vitro and in vivo as compared to wild type counterparts. The analogs are particularly useful for treating subjects showing low receptor expression or poor receptor responsiveness, and for the treatment of any condition associated with glycoprotein hormone activity..
| Far field diversion technique for treating subterranean formation|
Diverting compositions for treating a subterranean zone substantially distanced from a wellbore, comprising: a carrier fluid; and a particulate, partially dehydrated or anhydrous borate source material that does not substantially swell when placed in contact with the carrier fluid. The carrier fluid is capable of carrying and placing the borate source material into a stimulation network substantially distanced from a wellbore, and wherein the borate source material is dissolvable through sufficient contact with an aqueous fluid.
| Readied in situ glyphosate herbicide soluble powder composition and its preparation process|
This invention relates to readied in situ glyphosate herbicide soluble powder compositions of high efficiency and low toxicity useful for killing and/or controlling weeds. This invention is also related to a process to prepare the said compositions.
| Photosensitive resin composition for ctp flexographic printing original plate and printing original plate prepared therefrom|
A photosensitive resin composition for ctp flexographic printing original plate containing at least a hydrophobic polymer obtained from water-dispersible latex (a), a hydrophilic polymer (b), a photopolymerizable unsaturated compound (c), a photopolymerization initiator (d), and if necessary, rubber (e), characterized in that, the photopolymerizable unsaturated compound (c) comprises a photopolymerizable oligomer containing no hydroxyl group (c-1), a hydroxyl group-containing photopolymerizable monomer having a pentaerythritol skeleton, a dipentaerythritol skeleton or a glycerol skeleton (c-2) and, optionally, a photopolymerizable monomer containing no hydroxyl group (c-3). The content of the hydroxyl group-containing photopolymerizable monomer (c-2) is 1 to 20% by mass of the photosensitive resin composition.
| Conjugated fiber, base body for artificial leather, and artificial leather|
The present invention provides a conjugated fiber suitable for use as a crimped fiber capable of producing an artificial leather having highly dense texture and good quality. The present invention also provides a base body for an artificial leather and an artificial leather produced by using such conjugated fiber.
| Methods for using rebaudioside c as a flavor enhancer|
The present invention is directed to the use of one or more rebaudioside c polymorphs, or stereoisomers thereof, to enhance the sweet taste of luo han guo or luo han guo in combination with one or more of steviol-based glycosides or rebaudioside a.. .
| Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partsum|
A method and product for improving maternal and child health through nutrition. Omega-6 fatty acid and/or omega-3 fatty acid are provided to a woman and/or child prior to, during and/or after pregnancy to improve the health of the woman and her child.
| Polymer conjugated protein micelles|
The invention encompasses micelle assemblies, compositions having micelle assemblies, and methods for preparing micelle assemblies and compositions thereof. The invention also encompasses a prolamine protein conjugated to a polymer, such as a polyethylene glycol (peg) chain, which conjugates can be used to prepare micelle assemblies.
| Stabilized granules containing glyceryl trinitrate|
Solid pharmaceutical preparation with the active substance glyceryl trinitrate for oromucosal or oral administration characterized in that it contains between 0.05 and 2 weight % glyceryl trinitrate, at least one carrier material, and at least one substance that reduces the volatility of the gtn, whereby this substance is a non-volatile ester stabilizer.. .
| Products and methods|
The invention relates to fungal cells and spores, as well as extracts of either, for use, in particular, in prevention or treatment of chlamydia, or helicobacter pylori or other infections, inflammation, inflammatory, lysosomal, acidic, sod- or igg or other immunoglobulin—peroxidases or hydrogen peroxide induced or other forms of oxidative damage, atherosclerosis, heart disease, stomach, intestinal and liver inflammatory conditions and their complications, promoting or stimulating regeneration or healing of wounds, burns, ulcers, or other forms of damaged or aged tissues, or in reducing elevated cholesterol and/or triglycerides levels in a preferred instance, the fungal cells or spores are those used in the manufacture of fungal fermented cheeses or other food stuff or beverages, particular fungal blue or white cheeses.. .
| Vesicular stomatitis virus for prime boost vaccine|
The present invention relates to vesicular stomatitis virus (vsv) matrix (m) protein mutants. One mutant m protein includes a glycine changed to a glutamic acid at position (21), a leucine changed to a phenylalanine at position (111) and a methionine changed to an arginine at position (51).
| Bifidobacterium cect 7765 and use thereof in the prevention and/or treatment of overweight, obesity and associated pathologies|
The present invention relates to the bifidobacterium cect 7765 strain, to its cell components, metabolites, and secreted molecules, to the combinations thereof with other microorganisms, and to compositions comprising the aforementioned products, as well as to the use of a strain of the bifidobacterium pseudocatenulatum species, or to using the cect 7765 strain for the prevention and/or treatment of obesity, overweight, hyperglycemia and diabetes, preferably type 2 diabetes mellitus, hepatic steatosis or fatty liver, dyslipidemia, metabolic syndrome, immune system dysfunction associated with obesity and overweight; and an unbalanced composition of the intestinal microbiota associated with obesity and overweight.. .
| Fluorescence imparting agent for ceramics|
Provided is a fluorescence imparting agent for ceramics that does not require the use of an acidic solution during production. The fluorescence imparting agent for ceramics is a water solution containing 5 to 90% by weight of glycerin and 0.01 to 10% by weight of one or more bismuth compound selected from bismuth bromide (bibr3), bismuth bromate (bi(bro3)3), bismuth chloride (bicl3), bismuth chlorate (bi(clo3)3), bismuth fluoride (bif3), bismuth pentafluoride (bif5), bismuth hydroxide (bi(oh)3), bismuth iodide (bii3), bismuth iodate (bi(io3)3), bismuth nitrate (bi(no3)3), bismuth subnitrate (bi5o(oh)9(no3)4), bismuth phosphate (bipo4), and bismuth sulfate (bi2(so4)3)..
| Composition for electronic cigarettes|
The present invention relates to a new vegetable-based composition for liquid to be vaporized in electronic cigarettes, comprising water and propylen glycol of vegetable origin and/or glycerol and/or nicotine and/or natural flavors.. .
|Media interface tools and animations|
Disclosed herein are systems, methods, and non-transitory computer-readable storage media for displaying display primary e-book content, note glyphs and margins in an e-book interface according to the size of the e-book interface; animating “peeking pages” and glyph size during and after re-sizing events; selecting text in an e-book, entering a note that will become linked to the selected text, and representing the presence of the note on top of the primary content of the e-book as an interactive glyph according to some embodiments of the present technology; and displaying note objects, editing note objects, and navigating between note objects in a note-view pane of an e-book interface according to some embodiments of the present technology.. .
|Systems and methods for pattern recognition in diabetes management|
A diabetes management system or process is provided herein that may be used to analyze and recognize patterns for a large number of blood glucose concentration measurements and other physiological parameters related to the glycemia of a patient. In particular, a method of monitoring glycemia in a patient may include storing a patient's data on a suitable device, such as, for example, a blood glucose meter.
|Process for making esters|
The invention relates to a process for making esters, in particular biodiesel, using heterogeneous catalysts. The invention provides a process for making biodiesel, in particular fame, which process is versatile and robust.
|Artificial lipid-polymer-dna complex, bioimaging agent and preparation method thereof|
An artificial lipid-polymer-dna complex, an in-vivo imaging agent, a pharmaceutical composition and a method of preparing the same are provided. The artificial lipid bilayer includes a polymer matrix including polylactic-co-glycolic acid disposed within a lipid membrane..
|Functionalizing reagents and their uses|
Reagents and methods for functionalizing polypeptides with moieties (alkylene glycol) molecules and glycan groups are disclosed that are based on a functionalizing reagent which comprises a nitrogen containing heterocyclic aromatic ring having a vinyl substituent that is capable of reacting with one or more thiol groups that are naturally present, or have been introduced into, the polypeptide, for example by employing a thiol group of one or more cysteine residues. The functionalizing reagent is covalently linked to a poly(alkylene glycol) molecule, such as a polyethylene glycol (peg) molecule, or a glycan group so that the reaction between the vinyl group and the thiol group in the polypeptide covalently links the polypeptide to the poly(alkylene glycol) molecule and/or the glycan group..
The present invention relates to an ink composition suitable for being ejected from an inkjet marking device at an operating temperature. The ink composition comprises a water-dispersible resin and has a dynamic surface tension of below 35 mn/m and a static surface tension of above 21 mn/m both determined at the operating temperature.
|Polyol formulations for improved cold temperature skin cure of polyurethane rigid foams|
A polyol formulation comprising certain type of polyester polyols useful in the preparation of rigid polyurethane foams having low surface friability is provided. In one embodiment, a reaction system for production of a rigid foam is provided.
|Compositions for the production of a hydrophilic polystyrene article|
The invention relates to the use of two components in the joint extrusion with a polystyrene in order to increase the hydrophilic properties of the processed solid or foamed polystyrene film, sheet or food tray. The first component being an alkyl sulfonate, alkylbenzene sulfonate or olefin sulfonate, the second component is a polyethylene glycol, the two components can also be used in form of a composition, the composition being in the form of a masterbatch or of a compound..
|Ready-to-use co-solvents pharmaceutical composition in modified flexible plastic container|
A ready-to-use injectable, co-solvents (ternary mixture) pharmaceutical composition for the treatment of cardiac conditions and diagnosis applications, comprising methyl-3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride (esmolol hydrochloride), a buffering agent, ethanol and propylene glycol which capable of been stored in modified flexible plastic container, heat-sterilized without deformation and/or integrity of the closure system been compromised, as well as method for its manufacture, is disclosed.. .
|Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof|
In various embodiments, the present invention provides methods of treating and/or preventing cardiovascular-related disease and, in particular, a method of reducing triglycerides in a subject on rosiglitazone therapy, the method comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.. .
|Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux|
One aspect of the present invention relates to a method of treating or preventing pathologic sequelae of acute hyperglycemia and/or increased fatty acid flux in a subject. This method involves administering an ros inhibitor to the subject.
|Novel liquid organopolysiloxane and uses thereof|
A liquid organopolysiloxane having fluidity at least 100° c., a silicon-bonded glycerin derivative group, and a crosslinked structure comprising a carbon-silicon bond at the crosslinking portion.. .
|Novel enteric combination therapy|
There is disclosed herein a composition for treating gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers' diarrhoea, chronic idiopathic nausea, ibd-associated constipation and diarrhoea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, parkinson's disease, ms, alzheimer's disease, motor neurone disease or autism, the composition comprising: (i) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (ii) at least one anti-clostridial agent selected from the above combined with an opioid blocking agent. There is also disclosed herein a method of treating various gastrointestinal or neurological disorders, constipation, functional constipation, irritable bowel syndrome, diverticulitis, travelers' diarrhoea, chronic idiopathic nausea, ibd-associated constipation and diarrhoea, pseudo-obstruction, diabetic gastroparesis, cyclic vomiting, reflux oesophagitis, autism enteropathy, flatulence, halitosis, chronic fatigue, bloating, proctalgia fugax, parkinson's disease, ms, alzheimer's disease, motor neurone disease or autism, the method comprising administering orally, via enema or by suppository: (i) a composition of the invention; (ii) at least two anti-clostridial agents selected from the group consisting of: vancomycin, vancomycin derivatives, a multi-valent polymer of vancomycin, aminoglycosides, nitroimidazoles, ansamysins, nifuroxazide, colchicine, prucalopride, prokinetic agent and 5-aminosalicylic acid; or (iii) at least one anti-clostridial agent selected from the above and an opioid blocking agent to a patient in need of such treatment..
|Glycosaminoglycans for chemokine drug delivery|
A pharmaceutical composition for sustained release of a chemokine is described that includes a polymer bonded to a sulfated glycosaminoglycan and loaded with a chemokine having affinity for the sulfated glycosaminoglycan. The pharmaceutical composition can be used in a method for providing sustained release of a chemokine to subject by contacting the subject with the pharmaceutical composition..
|Herbicidal compositions containing n-phosphonomethyl glycine and an auxin herbicide|
Herbicidal compositions are provided which cause rapid symptomology while delivering long term control of regrowth of plants. The herbicidal concentrate compositions comprise n-phosphonomethylglycine or a herbicidal derivative thereof, an auxin herbicide or a herbicidal derivative thereof, and at least one surfactant.
|Transgenic plants and methods of using same|
Provided herein are plants having altered expression of a coding region encoding a hydroxyproline-rich glycoprotein. In some embodiments the expression is decreased, and the resulting plant has decreased recalcitrance, increased growth, or a combination thereof.
|Process for producing cellulase mixtures from myceliophthora and related organisms|
The present invention provides a fermentation process for producing a cellulase enzyme mixture comprising the steps of (a) providing a fungal cell of the genus myceliophthora or a taxonomically equivalent genus; (b) culturing the fungal cell in a submerged liquid batch culture in which the carbon source comprises about 0% of cellulase-inducing carbon source; (c) culturing the fungal cell from the batch culture from step (b) in a submerged liquid fed-batch and/or continuous culture; and (d) providing the culture of step (c) with a feed solution containing a about 100 wt % non-inducing carbon source (such as glucose, dextrose, sucrose, molasses, fructose, glycerol, xylose, or a combination thereof), wherein the feed solution is provided at a rate that maintains the concentration of non-inducing carbon source in the culture below that which would otherwise repress production of the cellulase enzyme mixture, so as to produce a culture filtrate containing at least 10 g protein/l.. .
|Controlling heat induced foam generation of foodstuff|
The present invention relates to the use of a composition to control the degree of heat induced foam generation in a foodstuff system when said foodstuff system is heated, wherein the composition comprises polyglycerol polyricinoleic acid.. .
|Fiber enriched filling composition for a chocolate product|
The present invention is directed to a fiber enriched filling composition for a chocolate product. The chocolate product includes (a) a steviol glucoside and/or steviol glycoside, (b) fat, (c) fibers, and (d) a polyol.
|Dentric polyglycerol sulfates and sulfonates and their use for inflammatory diseases|
The present invention relates to the novel compound classes of dendritic polyglycerol sulfates and sulfonates as well as to their production and use for the treatment of diseases, particularly inflammatory diseases, and to their use as selectin inhibitors and selectin indicators. The dendritic polyglycerol sulfates and sulfonates are also suitable for imaging diagnostics, particularly with respect to inflammatory diseases..
|Methods for reducing or altering scar formation|
Glycerophosphate salts have been found to hasten the healing of wounds and minimize the formation of scars, particularly when it is first applied to a wound about 0 to about 7 days after the wound is inflicted. Methods and compositions are provided for treating wounds using a composition comprising an effective amount of glycerophosphate salt.
|Telodendrimers with enhanced drug delivery|
The present invention provides amphiphilic telodendrimers that aggregate to form nanocarriers characterized by a hydrophobic core and a hydrophilic exterior. The nanocarrier core may include amphiphilic functionality such as cholic acid or cholic acid derivatives, and the exterior may include branched or linear poly(ethylene glycol) segments.
|Silicone hydrogel soft contact lens having wettable surface|
Provided is a silicone hydrogel soft contact lens obtained by curing in a double-sided casting mold, a liquid mixture including glycerol mono(meth)acrylate and at least one type of silicone monomer having at least one hydroxyl group or polyethylene glycol group in the molecular structure thereof, the silicone hydrogel soft contact lens having a wettable surface without a polymerized lens-shaped material being subjected to post-processing to improve the water wetting properties of a surface thereof.. .
|Layered z-order and hinted color fonts with dynamic palettes|
Technologies are generally provided for a set of data structures and font design techniques residing in a font file that enables the rich use of color that can be scaled for many devices with many resolutions and displayed on many types of colored backgrounds. Glyphs in a font may be ordered to provide z-ordering of layered color data.
|Movement of position indicator on touchscreen|
Some embodiments provide a method that displays a document that includes several glyphs on a touch screen display. The method receives a touch input on the touch screen display to activate a zoom tool enabling location of a position indicator within a set of associated glyphs.
Popular terms: [SEARCH]
Gly topics: Door Assembly, Swimming Goggles, Transverse, Alkoxylate, Fluoropolymer, Air Cleaning, Rotor Shaft, Aspect Ratio, Disconnect, Synchronization, Remote Control, Ethylene Glycol, Surfactant, Combustion, Steviol Glycosides
Follow us on Twitter
This listing is a sample listing of patent applications related to Gly for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Gly with additional patents listed. Browse our RSS directory or Search for other possible listings.